Sohm Announces Its Acquisition Of Abbie, A World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
Sohm Announces Its Acquisition Of Abbie, A World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
09/26/23, 1:34 PM
Industry
pharmaceutical
biotechnology
health care
manufacturing
via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today that it has acquired:
Company Info
Company info
SOHM, Inc. is a growing generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” that aims to build continuous growth. SOHM manufacturing and marketing targets rapidly growing healthcare segments such as nutraceuticals, cosmeceuticals and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India and strategic alliances with U.S. manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America and Southeast Asia.
To learn more about SOHM, Inc., visit www.SOHM.com.